Get the Stockscreener App
16.22
8.56%
-1.4197
Instil Bio Inc stock is traded at $16.22, with a volume of 43,693.
It is down -8.56% in the last 24 hours and down -10.88% over the past month.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
See More
Previous Close:
$17.64
Open:
$17.61
24h Volume:
43,693
Relative Volume:
0.33
Market Cap:
$108.42M
Revenue:
-
Net Income/Loss:
$-74.14M
P/E Ratio:
-1.4241
EPS:
-11.39
Net Cash Flow:
$-65.70M
1W Performance:
-18.82%
1M Performance:
-10.88%
6M Performance:
+11.40%
1Y Performance:
-43.95%
1-Day Range:
$16.05
$17.61
1-Week Range:
$16.13
$19.91
52-Week Range:
$10.80
$42.79
Instil Bio Inc Stock (TIL) Company Profile
Name
Instil Bio Inc
Sector
Industry
Phone
(972) 499-3350
Address
3963 MAPLE AVENUE, DALLAS
Compare TIL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TIL
Instil Bio Inc
|
16.06 | 119.08M | 0 | -74.14M | -65.70M | -11.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.76 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.33 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.40 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
821.30 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.16 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Instil Bio Inc Stock (TIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-07-25 | Upgrade | Jefferies | Hold → Buy |
| Nov-04-24 | Initiated | JMP Securities | Mkt Perform |
| Apr-12-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Nov-01-22 | Downgrade | Truist | Buy → Hold |
| Aug-13-21 | Initiated | Robert W. Baird | Outperform |
| Apr-13-21 | Initiated | Cowen | Outperform |
| Apr-13-21 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-21 | Initiated | Truist | Buy |
View All
Instil Bio Inc Stock (TIL) Latest News
Can Instil Bio Inc. stock deliver consistent earnings growth2025 Breakouts & Breakdowns & AI Forecast for Swing Trade Picks - newser.com
Can Instil Bio Inc. stock maintain growth trajectoryQuarterly Earnings Report & Technical Pattern Recognition Alerts - newser.com
Is Instil Bio Inc. stock attractive for long term wealth buildingJuly 2025 Earnings & Expert Verified Movement Alerts - newser.com
How Instil Bio Inc. stock reacts to job market data2025 Earnings Surprises & High Accuracy Investment Entry Signals - newser.com
Applying big data sentiment scoring on Instil Bio Inc.Trend Reversal & Expert Verified Stock Movement Alerts - newser.com
What hedge fund activity signals for Instil Bio Inc. stock2025 Earnings Impact & AI Enhanced Trading Signals - newser.com
Signal strength of Instil Bio Inc. stock in tech scanners2025 Short Interest & Consistent Profit Alerts - newser.com
Heatmap analysis for Instil Bio Inc. and competitorsJuly 2025 Macro Moves & Weekly Consistent Profit Watchlists - newser.com
Will Instil Bio Inc. stock benefit from automationJuly 2025 Market Mood & Technical Pattern Recognition Alerts - newser.com
Chart based exit strategy for Instil Bio Inc.2025 Sector Review & Real-Time Buy Signal Notifications - newser.com
Why Instil Bio Inc. stock could benefit from AI revolution2025 Key Highlights & Consistent Return Investment Signals - newser.com
Why Instil Bio Inc. stock remains on buy listsProfit Target & Risk Controlled Swing Alerts - newser.com
Published on: 2025-11-02 21:10:11 - newser.com
Will Instil Bio Inc. stock maintain momentum in 2025Weekly Gains Report & Low Risk Entry Point Tips - newser.com
Regression analysis insights on Instil Bio Inc. performanceWeekly Investment Report & Technical Confirmation Alerts - newser.com
Evaluating Instil Bio Inc. with trendline analysisPortfolio Return Summary & Verified Swing Trading Watchlists - newser.com
Is Instil Bio Inc. showing signs of accumulationQuarterly Performance Summary & Risk Controlled Stock Pick Alerts - newser.com
Published on: 2025-10-31 05:53:37 - newser.com
Why Instil Bio Inc. stock appeals to analysts2025 Volatility Report & Low Drawdown Trading Techniques - newser.com
Key metrics from Instil Bio Inc.’s quarterly dataPortfolio Risk Summary & Accurate Buy Signal Alerts - newser.com
What to expect from Instil Bio Inc. in the next 30 days2025 Performance Recap & Consistent Income Trade Ideas - newser.com
Instil Bio Inc Stock (TIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.33%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):